cisplatin ^Turanci (Q412415)

Daga Wikidata

Jump to navigation Jump to search

pharmaceutical drug ^Turanci

gyara

Language	Label	Description	Also known as
Hausa	Ba suna a kai	Ba'a bayyana ma'ana ba
Turanci	cisplatin	pharmaceutical drug	Platinol CIS-DDP Platinol-AQ CDDP cis-diamminedichloroplatinum(II) Cis-DDP

Statements

iri

type of chemical entity ^Turanci

0 references

Ƙaramin ɓangare na

chemical compound ^Turanci

0 references

bangare na

response to cisplatin ^Turanci

subject has role ^Turanci

reactant ^Turanci

1 reference

stated in ^Turanci

Gene Ontology release 2019-11-16 ^Turanci

cellular response to cisplatin ^Turanci

subject has role ^Turanci

reactant ^Turanci

1 reference

stated in ^Turanci

Gene Ontology release 2019-11-16 ^Turanci

amfani

magani

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

00515

harshen aiki ko suna

Turanci

laƙabi

Cisplatin (Turanci)

ranar wallafa

23 Satumba 2015

tsarin sinadaran

Cisplatin-stereo.svg
512 × 310; 5 KB

0 references

image of molecular model or crystal lattice model ^Turanci

Cisplatin-3D-balls.png
1,100 × 914; 229 KB

depicts ^Turanci

ball-and-stick model ^Turanci

0 references

Taro

298.955595 dalton

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

5702198

harshen aiki ko suna

Turanci

laƙabi

14913-33-8 (Turanci)

retrieved ^Turanci

27 Satumba 2016

sinadaran dabara

Cl₂H₆N₂Pt

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

5702198

harshen aiki ko suna

Turanci

laƙabi

14913-33-8 (Turanci)

retrieved ^Turanci

27 Satumba 2016

canonical SMILES ^Turanci

N.N.Cl[Pt]Cl

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

5702198

harshen aiki ko suna

Turanci

laƙabi

14913-33-8 (Turanci)

retrieved ^Turanci

27 Satumba 2016

World Health Organisation international non-proprietary name ^Turanci

Cisplatin (Turanci)

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

CHEMBL11359

harshen aiki ko suna

Turanci

laƙabi

Cisplatin (Turanci)

retrieved ^Turanci

9 Oktoba 2015

medical condition treated ^Turanci

lung oat cell carcinoma ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

Ciwon Daji na Kai da Wuya

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

ciwon nono

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

esophageal cancer ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

Hodgkin's lymphoma, mixed cellularity ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

Osteosarcoma

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

amelanotic melanoma ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

lung benign neoplasm ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

Multiple myeloma

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

spindle cell sarcoma ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

Ciwon daji na prostate

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

lymphosarcoma ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

Ciwon Daji Na Ovarian

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

stomach cancer ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

Kansar Mahaifa

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

bladder cancer ^Turanci

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

subependymal giant cell astrocytoma ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

neuroblastoma ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

germ cell cancer ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

transitional cell carcinoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

tongue squamous cell carcinoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

hepatoblastoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

head and neck squamous cell carcinoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

laryngeal cancer ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

non-small-cell lung carcinoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

gastric adenocarcinoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

bone sarcoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

neuroblastoma, susceptibility to ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

bladder cancer ^Turanci

lokacin farawa

19 Disamba 1978

approved by ^Turanci

Hukumar Abinci da Magunguna

1 reference

stated in ^Turanci

Inxight: Drugs Database ^Turanci

retrieved ^Turanci

2 Nuwamba 2018

adireshin manazarta

https://drugs.ncats.io/drug/Q20Q21Q62J

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018057s083lbl.pdf

Ciwon Daji Na Ovarian

lokacin farawa

19 Disamba 1978

approved by ^Turanci

Hukumar Abinci da Magunguna

1 reference

stated in ^Turanci

Inxight: Drugs Database ^Turanci

retrieved ^Turanci

2 Nuwamba 2018

adireshin manazarta

https://drugs.ncats.io/drug/Q20Q21Q62J

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018057s083lbl.pdf

Kansar Mahaifa

lokacin farawa

19 Disamba 1978

approved by ^Turanci

Hukumar Abinci da Magunguna

1 reference

stated in ^Turanci

Inxight: Drugs Database ^Turanci

retrieved ^Turanci

2 Nuwamba 2018

adireshin manazarta

https://drugs.ncats.io/drug/Q20Q21Q62J

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018057s083lbl.pdf

significant drug interaction ^Turanci

furosemide ^Turanci

matsalar da zata iya haifarwa

ototoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tobramycin ^Turanci

matsalar da zata iya haifarwa

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fosphenytoin ^Turanci

matsalar da zata iya haifarwa

peripheral neuropathy ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

phenytoin ^Turanci

matsalar da zata iya haifarwa

peripheral neuropathy ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tobramycin ^Turanci

matsalar da zata iya haifarwa

ototoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

furosemide ^Turanci

matsalar da zata iya haifarwa

nephrotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tobramycin ^Turanci

matsalar da zata iya haifarwa

kidney failure ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

legal status (medicine) ^Turanci

boxed warning ^Turanci

1 reference

adireshin manazarta

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

laƙabi

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (Turanci)

pregnancy category ^Turanci

US pregnancy category D ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

subject has role ^Turanci

DNA polymerase inhibitors ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

retrieved ^Turanci

5 Maris 2018

antineoplastic ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

D002945

retrieved ^Turanci

15 Maris 2018

cross-linking reagent ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

D002945

retrieved ^Turanci

15 Maris 2018

radiosensitizer ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

D002945

retrieved ^Turanci

15 Maris 2018

carcinogen ^Turanci

1 reference

stated in ^Turanci

California Proposition 65 list of chemicals ^Turanci

retrieved ^Turanci

21 Faburairu 2020

adireshin manazarta

https://oehha.ca.gov/chemicals/cisplatin

platinum-based antineoplastic ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

retrieved ^Turanci

27 Faburairu 2018

essential medicine ^Turanci

0 references

stylized name ^Turanci

CISplatin

has characteristic ^Turanci

Tall Man lettering ^Turanci

issued by ^Turanci

Hukumar Abinci da Magunguna

subject named as ^Turanci

Cisplatin

1 reference

adireshin manazarta

https://www.fda.gov/drugs/medication-errors-related-cder-regulated-drug-products/fda-name-differentiation-project

retrieved ^Turanci

2 Satumba 2022

has part(s) ^Turanci

platinum ^Turanci

0 references

Commons category ^Turanci

Cisplatin

0 references

Identifiers

National Library of Israel J9U ID ^Turanci

987007286296705171

1 reference

stated in ^Turanci

National Library of Israel Names and Subjects Authority File ^Turanci

NL CR AUT ID ^Turanci

ph707356

subject named as ^Turanci

cisplatina

0 references

InChI ^Turanci

InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

5702198

harshen aiki ko suna

Turanci

laƙabi

14913-33-8 (Turanci)

retrieved ^Turanci

27 Satumba 2016

InChIKey ^Turanci

LXZZYRPGZAFOLE-UHFFFAOYSA-L

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

5702198

harshen aiki ko suna

Turanci

laƙabi

14913-33-8 (Turanci)

retrieved ^Turanci

27 Satumba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

15663-27-1

2 references

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

00515

harshen aiki ko suna

Turanci

laƙabi

Cisplatin (Turanci)

ranar wallafa

23 Satumba 2015

stated in ^Turanci

CAS Common Chemistry ^Turanci

retrieved ^Turanci

6 Afirilu 2021

adireshin manazarta

https://commonchemistry.cas.org/detail?cas_rn=15663-27-1

InChIKey ^Turanci

LXZZYRPGZAFOLE-UHFFFAOYSA-L

ChemSpider ID ^Turanci

76401

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

76401

harshen aiki ko suna

Turanci

laƙabi

CIS-PLATIN (Turanci)

retrieved ^Turanci

27 Satumba 2016

PubChem CID ^Turanci

5702198

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

5702198

harshen aiki ko suna

Turanci

laƙabi

14913-33-8 (Turanci)

retrieved ^Turanci

27 Satumba 2016

matched by identifier from ^Turanci

InChIKey ^Turanci

InChIKey ^Turanci

LXZZYRPGZAFOLE-UHFFFAOYSA-L

84691

1 reference

matched by identifier from ^Turanci

InChIKey ^Turanci

InChIKey ^Turanci

LXZZYRPGZAFOLE-UHFFFAOYSA-L

5460033

1 reference

matched by identifier from ^Turanci

InChIKey ^Turanci

InChIKey ^Turanci

LXZZYRPGZAFOLE-UHFFFAOYSA-L

Gmelin number ^Turanci

2519

0 references

ChEBI ID ^Turanci

27899

mapping relation type ^Turanci

exact match ^Turanci

2 references

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

CHEMBL11359

harshen aiki ko suna

Turanci

laƙabi

Cisplatin (Turanci)

retrieved ^Turanci

9 Oktoba 2015

matched by identifier from ^Turanci

International Chemical Identifier ^Turanci

InChI ^Turanci

InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

35852

mapping relation type ^Turanci

exact match ^Turanci

1 reference

matched by identifier from ^Turanci

International Chemical Identifier ^Turanci

InChI ^Turanci

InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

ChEMBL ID ^Turanci

CHEMBL11359

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

CHEMBL11359

harshen aiki ko suna

Turanci

laƙabi

Cisplatin (Turanci)

retrieved ^Turanci

9 Oktoba 2015

UniChem compound ID ^Turanci

292460

1 reference

stated in ^Turanci

UniChem ^Turanci

CAMEO Chemicals ID ^Turanci

24020

0 references

UN number ^Turanci

3288

1 reference

an ɗauko daga

Russian Wikipedia ^Turanci

RTECS number ^Turanci

TP2450000

1 reference

an ɗauko daga

Russian Wikipedia ^Turanci

ZVG number ^Turanci

490577

1 reference

an ɗauko daga

German Wikipedia ^Turanci

HSDB ID ^Turanci

3939

1 reference

stated in ^Turanci

Hazardous Substances Data Bank ^Turanci

HSDB ID ^Turanci

3939

ranar wallafa

28 Oktoba 2019

laƙabi

CIS-DIAMINEDICHLOROPLATINUM (Turanci)

retrieved ^Turanci

10 Mayu 2021

DSSTox substance ID ^Turanci

DTXSID50275807

1 reference

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

DSSTOX compound identifier ^Turanci

DTXCID90227183

0 references

NSC number ^Turanci

119875

0 references

758184

0 references

EC number ^Turanci

239-733-8

1 reference

an ɗauko daga

Russian Wikipedia ^Turanci

ECHA Substance Infocard ID ^Turanci

100.036.106

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.036.106

retrieved ^Turanci

27 Disamba 2018

laƙabi

cisplatin (Turanci)

quotation ^Turanci

CAS no.: 15663-27-1 (Turanci)

AICS Chemical ID (BEING DELETED) ^Turanci

14237

0 references

Lambar ATC

L01XA01

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

00515

harshen aiki ko suna

Turanci

laƙabi

Cisplatin (Turanci)

ranar wallafa

23 Satumba 2015

Guide to Pharmacology Ligand ID ^Turanci

5343

0 references

MeSH descriptor ID ^Turanci

D002945

subject named as ^Turanci

Cisplatin

0 references

Lambar itace MeSH

D01.210.375

0 references

D01.625.125

0 references

D01.710.100

0 references

RxNorm ID ^Turanci

2555

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

retrieved ^Turanci

26 Faburairu 2018

DrugBank ID ^Turanci

00515

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

00515

laƙabi

Cisplatin (Turanci)

ranar wallafa

23 Satumba 2015

DB00515

1 reference

matched by identifier from ^Turanci

InChIKey ^Turanci

InChIKey ^Turanci

LXZZYRPGZAFOLE-UHFFFAOYSA-L

Human Metabolome Database ID ^Turanci

HMDB0014656

0 references

UNII ^Turanci

Q20Q21Q62J

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

laƙabi

CISPLATIN (Turanci)

retrieved ^Turanci

9 Oktoba 2015

matched by identifier from ^Turanci

InChIKey ^Turanci

InChIKey ^Turanci

LXZZYRPGZAFOLE-UHFFFAOYSA-L

BW0OY6ZTD4

1 reference

matched by identifier from ^Turanci

InChIKey ^Turanci

InChIKey ^Turanci

LXZZYRPGZAFOLE-UHFFFAOYSA-L

MedlinePlus drug identifier ^Turanci

a684036

0 references

PatientsLikeMe treatment ID ^Turanci

cisplatin

0 references

NDF-RT ID ^Turanci

N0000146476

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000146476

harshen aiki ko suna

Turanci

laƙabi

CISPLATIN (Turanci)

retrieved ^Turanci

9 Oktoba 2015

Probes And Drugs ID ^Turanci

PD001382

0 references

KEGG ID ^Turanci

D00275

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

CHEMBL11359

harshen aiki ko suna

Turanci

laƙabi

Cisplatin (Turanci)

retrieved ^Turanci

9 Oktoba 2015

IEDB Epitope ID ^Turanci

194799

1 reference

stated in ^Turanci

Immune Epitope Database and Analysis Resource ^Turanci

IEDB Epitope ID ^Turanci

194799

retrieved ^Turanci

1 Maris 2022

PDB ligand ID ^Turanci

CPT

0 references

Brockhaus Enzyklopädie online ID ^Turanci

cisplatin

0 references

CA PROP 65 ID ^Turanci

cisplatin

1 reference

stated in ^Turanci

California Proposition 65 list of chemicals ^Turanci

retrieved ^Turanci

2 Disamba 2019

adireshin manazarta

https://oehha.ca.gov/chemicals/cisplatin

electronic Essential Medicines List medicine ID ^Turanci

79

0 references

Freebase ID ^Turanci

/m/04xnqp

1 reference

stated in ^Turanci

Freebase Data Dumps ^Turanci

ranar wallafa

28 Oktoba 2013

Gran Enciclopèdia Catalana ID ^Turanci

cisplati

0 references

Gran Enciclopèdia Catalana ID (former scheme) ^Turanci

0090769

0 references

Microsoft Academic ID ^Turanci

2778239845

0 references

NALT ID ^Turanci

10462

0 references

NE.se ID ^Turanci

cisplatin

0 references

OpenAlex ID ^Turanci

C2778239845

1 reference

stated in ^Turanci

OpenAlex ^Turanci

retrieved ^Turanci

26 Janairu 2022

adireshin manazarta

https://docs.openalex.org/download-snapshot/snapshot-data-format

Quora topic ID ^Turanci

Cisplatin

1 reference

stated in ^Turanci

Quora ^Turanci

UNSPSC Code ^Turanci

51111506

0 references

WikiProjectMed ID ^Turanci

Cisplatin

0 references

 

Sitelinks

Wikipedia(36 entries)

gyara

• arwiki سيسبلاتين
• azbwiki سیس‌پلاتین
• bswiki Cisplatin
• cawiki Cisplatí
• cywiki Cisplatin
• dewiki Cisplatin
• elwiki Σισπλατίνη
• enwiki Cisplatin
• eswiki Cisplatino
• euwiki Zisplatino
• fawiki سیس‌پلاتین
• fiwiki Sisplatiini
• frwiki Cisplatine
• hewiki ציספלאטין
• hiwiki सिसप्लेटिन
• huwiki Ciszplatin
• hywiki Ցիսպլատին
• idwiki Sisplatin
• itwiki Cisplatino
• jawiki シスプラチン
• kowiki 시스플라틴
• mkwiki Цисплатин
• nlwiki Cisplatine
• orwiki ସିସପ୍ଲାଟିନ
• plwiki Cisplatyna
• ptwiki Cisplatina
• rowiki Cisplatină
• ruwiki Цисплатин
• shwiki Cisplatin
• slwiki Cisplatin
• srwiki Cisplatin
• thwiki ซิสพลาติน
• trwiki Sisplatin
• ukwiki Цисплатин
• viwiki Cisplatin
• zhwiki 顺铂

Wikibooks(0 entries)

gyara

Wikinews(0 entries)

gyara

Wikiquote(0 entries)

gyara

Wikisource(0 entries)

gyara

Wikiversity(0 entries)

gyara

Wikivoyage(0 entries)

gyara

Wiktionary(0 entries)

gyara

Wasu shafuka(1 entry)

gyara

• commonswiki Category:Cisplatin

Daga "https://www.wikidata.org/w/index.php?title=Q412415&oldid=2162439356"